Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1988
Transglutaminase in cell proliferation and transformation
S Metafora, G Peluso, G Ravagnan, et al.
The Journal of Physiology
|
June 26, 2024
BMAL1 and CLOCK proteins exhibit differential association with mitochondrial dynamics, protein synthesis pathways and muscle strength in human muscle
A M Figueroa-Toledo, J Gutiérrez-Pino, A Carriel-Nesvara, et al.
Frontiers in Physiology
|
December 19, 2018
Disrupt of Intra-Limb APA Pattern in Parkinsonian Patients Performing Index-Finger Flexion
Francesco Bolzoni, Roberto Esposti, Silvia M Marchese, et al.
Frontiers in Pain Research (Lausanne, Switzerland)
|
March 17, 2022
Recommendations for Neuromodulation in Diabetic Neuropathic Pain
Zachary T Olmsted, Amir Hadanny, Anthony M Marchese, et al.
Journal of Virology
|
February 14, 2020
Mucin-Like Domain of Ebola Virus Glycoprotein Enhances Selective Oncolytic Actions against Brain Tumors
Xue Zhang, Tingting Zhang, John N Davis, et al.
Biochimica Et Biophysica Acta
|
April 20, 2000
Treatment of v-Ki-ras-transformed SVC1 cells with low retinoic acid induces malignancy reversion associated with ras p21 down-regulation
A Spina, E Chiosi, S Naviglio, et al.
European Journal of Pharmacology
|
March 18, 2000
Inhibition of antithrombin by protein SV-IV normalizes the coagulation of hemophilic blood
B Di Micco, J Caen, G Colonna, et al.
International Journal of Cancer
|
July 17, 1997
SV-IV, a major protein secreted from rat seminal vesicle epithelium, promotes lymphocyte cytotoxic activity against the lymphoblastoid Raji cell line in human peripheral blood mononuclear cells
G Peluso, M Marchese, A Furgi, et al.
Vaccines
|
July 27, 2024
Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines
Matthew D Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
Vaccine
|
May 1, 2023
NVX-CoV2373 vaccine efficacy against hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trial
Anthony M Marchese, Xiang Zhou, John Kinol, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1988
Transglutaminase in cell proliferation and transformation
S Metafora, G Peluso, G Ravagnan, et al.
The Journal of Physiology
|
June 26, 2024
BMAL1 and CLOCK proteins exhibit differential association with mitochondrial dynamics, protein synthesis pathways and muscle strength in human muscle
A M Figueroa-Toledo, J Gutiérrez-Pino, A Carriel-Nesvara, et al.
Frontiers in Physiology
|
December 19, 2018
Disrupt of Intra-Limb APA Pattern in Parkinsonian Patients Performing Index-Finger Flexion
Francesco Bolzoni, Roberto Esposti, Silvia M Marchese, et al.
Frontiers in Pain Research (Lausanne, Switzerland)
|
March 17, 2022
Recommendations for Neuromodulation in Diabetic Neuropathic Pain
Zachary T Olmsted, Amir Hadanny, Anthony M Marchese, et al.
Journal of Virology
|
February 14, 2020
Mucin-Like Domain of Ebola Virus Glycoprotein Enhances Selective Oncolytic Actions against Brain Tumors
Xue Zhang, Tingting Zhang, John N Davis, et al.
Biochimica Et Biophysica Acta
|
April 20, 2000
Treatment of v-Ki-ras-transformed SVC1 cells with low retinoic acid induces malignancy reversion associated with ras p21 down-regulation
A Spina, E Chiosi, S Naviglio, et al.
European Journal of Pharmacology
|
March 18, 2000
Inhibition of antithrombin by protein SV-IV normalizes the coagulation of hemophilic blood
B Di Micco, J Caen, G Colonna, et al.
International Journal of Cancer
|
July 17, 1997
SV-IV, a major protein secreted from rat seminal vesicle epithelium, promotes lymphocyte cytotoxic activity against the lymphoblastoid Raji cell line in human peripheral blood mononuclear cells
G Peluso, M Marchese, A Furgi, et al.
Vaccines
|
July 27, 2024
Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines
Matthew D Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
Vaccine
|
May 1, 2023
NVX-CoV2373 vaccine efficacy against hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trial
Anthony M Marchese, Xiang Zhou, John Kinol, et al.
Page
of 8